Variant t(11;22)(q13;q11.2) with <i>IGL</i> involvement in mantle cell lymphoma-Reference-Cited by-同舟云学术

Variant t(11;22)(q13;q11.2) with IGL involvement in mantle cell lymphoma

Published:2022-02-07 Issue:7 Volume:63 Page:1746-1749
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Cabirta Alba¹²^ORCID,Hidalgo-Gómez Gloria¹^ORCID,Marín-Niebla Ana¹²^ORCID,Gallur Laura¹²,Saumell Silvia¹²^ORCID,Castellví Josep³^ORCID,Catalá Eva¹²^ORCID,Blanco Adoración¹,López-Andreoni Laura¹²,Montoro María Julia¹²^ORCID,Navarrete Mayda¹²,Palacio-García Carlos¹²^ORCID,Tazón-Vega Bárbara¹,Bobillo Sabela¹²,Bosch Francesc¹²,Ortega Margarita¹^ORCID

Affiliation:

1. Department of Hematology, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain

2. Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain

3. Department of Pathology, Vall d'Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Barcelona, Spain

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2022.2034158

Reference15 articles.

1. Incidence and survival trends in mantle cell lymphoma

2. Mantle cell lymphoma

3. Current overview and treatment of mantle cell lymphoma

4. Update on mantle cell lymphoma

5. Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytogenetics in the management of mature B-cell non-Hodgkin lymphomas: Guidelines from the Groupe Francophone de Cytogénétique Hematologique (GFCH);Current Research in Translational Medicine;2023-10